Table: begin end state 1 573 cytoplasmic 574 594 transmembrane 595 731 non-cytoplasmic 732 754 transmembrane 755 780 cytoplasmic 781 802 transmembrane 803 809 non-cytoplasmic 810 832 transmembrane 833 838 cytoplasmic 839 858 transmembrane 859 900 non-cytoplasmic 901 921 transmembrane 922 926 cytoplasmic
Input: >WP_092052478.1 NCBI__GCF_900111775.1:WP_092052478.1 MTSPAPSGEISKTPPVAQLRDVSLRYKKTQALDSISLDLPSGGMVGFIGPDGVGKSSLFS LIAGARAIQTGSIDVLGGDMADRHHRRQVCPRVAYMPQGLGKNLYPTLSVYENAEFFGRL FGQDRQERQDRIDDLLAATGLSPFAGRPAGKLSGGMKQKLGLCCALIHDPDLLILDEPTT GVDPLSRRQFWELIERIRHNRPGMSVLVATAYMEEAARFDWLVAMNGGRVLATGTPAELL ERTGGESLEEAFIALLPEAQRESYEPIVIPPRNTDEDGQTAIEAQGLTMRFGDFTAVDHV DFRILRGEIFGFLGSNGCGKTTTMKILTGLLPATEGEARLFGHKVNAHDIETRRRVGYMT QGFSLYSELTVRQNLVLHARLFRMPEEKIPERVEEMAERFGLIGIMESLPDALPLGQRQR LSLAVAMIHAPEMLILDEPTSGVDPVARDGFWRIMIDLARREKVTIFISTHFMNEALRCD RISLMHAGKVLVSDAPRALMEKRGAATLEEAFISYLEEASAGPESAASPPPEKALPTPPA PSRERQHHPAGFFSLRRLLSYTRRESLELRRDPIRLTLALLGTLILMFVIGYGVNMDVED LTFAVLDRDQSALSRDYALNLSGSRYFIEHAPIRDYADMDRRMRAGEISLAIEIPPGFGR DLRRGSAVAIGAWIDGAMPQRAETVRGYAQGMHAHWLASVSRQARGEASTSGTVNIETRF RYNPDVKSLPSMVPAVIPLLLMMIPAMLTALSVVREKELGSIVNLYVTPVTRLEFLLGKQ IPYLALAMLNFLLLTALAVFVFKVPITGSFTALSTGALLYVCAATTLGMVISTFMRSQIA AIFGTAILTILPAVQFSGMLDPVSSLEGAGAVIGKIYPTTHFLTIARGTFSKALGFADLQ ASFIPLLLAVPILIGLGAVLLKKQER
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server